Holtec Nuclear, the spent-fuel storage leader and SMR-300 developer, files its S-1 and intends to apply to list on Nasdaq under ticker HNUC.
Standard Nuclear IPO Preview: America’s TRISO Fuel Pioneer Files to List
IPO preview of Standard Nuclear (STDN), the only US firm with industrial-scale TRISO fuel manufacturing, filing to list on the NYSE. Financials, risks and terms.
X-Energy IPO Preview: SMR Developer Eyes Nasdaq Debut with $750M Raise
X-Energy IPO preview: advanced SMR developer targeting $750M raise on Nasdaq under XE, backed by Amazon, Dow and Centrica with an 11+ GWe pipeline.
12 Listed Companies Developing Small Modular Reactors (SMRs)
Compare 12 listed SMR developers by reactor design, licensing progress, business exposure, funding needs and commercial deployment targets.
Meta and Oklo Inc. Announce 1.2 GW Nuclear Energy Agreement in Ohio
NEWS Published: January 9, 2026 | Category: Clean Energy – Nuclear Power Meta and Oklo Inc. Announce 1.2 GW Nuclear Energy Agreement in Ohio Oklo's proposed Aurora powerhouse facility in Pike County, Ohio will deliver 1.2 GW of nuclear capacity to Meta...
UK Selects Wylfa for First Rolls-Royce SMR Nuclear Plant
The UK government has confirmed Wylfa in North Wales as the site for Britain’s first small modular reactors, backed by over £2.5 billion in government funding and designed by Rolls-Royce SMR.
NRC Approves NuScale’s Uprated 77 MWe SMR Design
NuScale Power receives NRC Standard Design Approval for uprated 250 MWt (77 MWe) nuclear modules, marking the company’s second approved design and advancing commercialization timeline.
Terrestrial Energy SPAC Merger Preview: First Publicly Traded Molten Salt Reactor Developer
Terrestrial Energy merges with HCM II to list on Nasdaq as IMSR. Analysis of the $925M pre-money valuation, molten salt reactor technology, and SPAC deal terms.
Oklo Proposes $25M Acquisition of Atomic Alchemy to Enter Radioisotope Market
Oklo Inc. has signed a letter of intent to acquire Atomic Alchemy for $25 million in an all-stock deal, targeting the $55.7 billion radioisotope market with U.S.-based production facilities.